Stay updated on Nivolumab and SRS in Recurrent Meningioma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and SRS in Recurrent Meningioma Clinical Trial page.

Latest updates to the Nivolumab and SRS in Recurrent Meningioma Clinical Trial page
- Check7 days agoChange DetectedShow glossary was added; minor copy changes include the phrasing of 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and a new footer note 'Revision: v3.4.0'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check14 days agoChange DetectedUpdated study record dates include additions on 2026-01-20 and 2026-01-16, and deletions on 2026-01-13 and 2026-01-10. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check21 days agoChange DetectedAdministrative updates were logged: new revision notes (v3.3.4) dated 2026-01-10 and 2026-01-13, and deletions of earlier revisions (v3.3.3) dated 2026-01-03 and 2026-01-06. These changes do not modify the trial data, eligibility criteria, or outcomes presented on the page.SummaryDifference0.1%

- Check29 days agoChange DetectedNew update dates 2026-01-06 and 2026-01-03 appear in the study record, while the earlier dates 2025-12-30 and 2025-12-27 were removed. This change reflects updates to the record's revision history rather than any modification to the study content.SummaryDifference0.1%

- Check36 days agoChange DetectedThe study record history shows additions of update dates 2025-12-30 and 2025-12-27 and deletions of 2025-12-20 and 2025-12-23. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check43 days agoChange DetectedAdded a new Locations section listing participating sites across Arizona, California, Colorado, Florida, Kansas, Maryland, Minnesota, Missouri, Nebraska, New York, North Carolina, Pennsylvania, Texas, and Utah; updated the page revision to v3.3.3.SummaryDifference1%

Stay in the know with updates to Nivolumab and SRS in Recurrent Meningioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and SRS in Recurrent Meningioma Clinical Trial page.